Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters

Language
Document Type
Year range
1.
Annals of Allergy Asthma & Immunology ; 128(6):733-734, 2022.
Article in English | Web of Science | ID: covidwho-1976301
4.
Astim Allerji Immunoloji ; 18:27-29, 2020.
Article in English | Web of Science | ID: covidwho-965818

ABSTRACT

Coronavirus disease 2019 (COVID-19) originated in Wuhan, China, and caused a pandemic in the world. SARS-CoV-2 infections have a great health risk, especially in patients with chronic diseases. There are concerns that COVID-19 will be more severe in patients with severe asthma. The efficacy and safety of biological agents used in severe asthmatics during SARS-CoV-2 infections are currently unknown. In this case report, we present a patient who had been using omalizumab for five years with the diagnosis of severe asthma and died due to COVID-19. To the best of our knowledge, this is the first case of a Turkish patient who died due to COVID-19 under omalizumab treatment for severe asthma.

SELECTION OF CITATIONS
SEARCH DETAIL